vs

Side-by-side financial comparison of Adagio Medical Holdings, Inc. (ADGM) and Stevanato Group S.p.A. (STVN). Click either name above to swap in a different company.

Adagio Medical Holdings, Inc. is a medical technology company focused on developing and commercializing innovative cryoablation platforms for treating cardiac arrhythmias, most notably atrial fibrillation. Its solutions are designed for electrophysiology clinicians, with primary commercial operations across North America and Europe, focused on improving safety and outcomes for patients living with heart rhythm disorders.

Stevanato Group is an Italian multinational company headquartered in Piombino Dese, Padua – Italy. Founded in 1949, it is also active in the glass tube forming technology and inspection systems sector.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADGM
ADGM
STVN
STVN
Q3 25
$0
Q3 24
$132.0K
Q2 24
$254.0K
Net Profit
ADGM
ADGM
STVN
STVN
Q3 25
$-10.1M
Q3 24
$3.6M
Q2 24
$-5.7M
Gross Margin
ADGM
ADGM
STVN
STVN
Q3 25
Q3 24
-213.6%
Q2 24
-168.5%
Operating Margin
ADGM
ADGM
STVN
STVN
Q3 25
Q3 24
-3352.3%
Q2 24
-2621.7%
Net Margin
ADGM
ADGM
STVN
STVN
Q3 25
Q3 24
2731.8%
Q2 24
-2257.5%
EPS (diluted)
ADGM
ADGM
STVN
STVN
Q3 25
$-0.66
Q3 24
$0.02
Q2 24
$-7.35

Related Comparisons